Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome	Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Recruiting	Phase 1	2025-12-23		NCT04245397

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AdventHealth	44
Emory University	393
H. Lee Moffitt Cancer Center and Research Institute	162
Mayo Clinic	970
Montefiore Medical Center	93
National Cancer Institute (NCI)	3015
National Heart, Lung, and Blood Institute (NHLBI)	791
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	117
Syntrix Biosystems, Inc.	9
University of Miami	277

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AdventHealth Medical Group & Bone Marrow Transplant at Orlando	Orlando	United States	1
Emory University	Atlanta	United States	262
Mayo Clinic	Jacksonville	United States	122
Moffitt Cancer Center	Tampa	United States	523
Montefiore Medical Center	The Bronx	United States	198
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Baltimore	United States	24
University of Miami	Miami	United States	327